Gubra AS (CHIX:GUBRAC) FFO


CHIX:GUBRAC Gubra AS CHIX:GUBRAC
73 GF Score
Price kr354.50
GF Value kr3,128.12
! 3 Warning Signs
View Full Analysis

What is Gubra AS FFO?

FFO (Funds from operations) only applies to REITs.

CHIX:GUBRAC
73GF Score
Gubra AS CHIX:GUBRAC
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Gubra AS (CHIX:GUBRAC) Overvalued in 2026?

Based on GuruFocus' analysis, Gubra AS stock appears to be undervalued. The current stock price of kr354.50 is trading 88.7% below its estimated GF Value™ of kr3,128.12.

Key valuation signals for CHIX:GUBRAC:

  • FFO:
  • GF Value™: kr3,128.12 vs. price of kr354.50 (88.7% below fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the CHIX:GUBRAC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Gubra AS Business Description

Other Exchanges GUBRA:DenmarkPI3:Germany
Address Horsholm Kongevej 11B, Horsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. The company has two segments: Pre-clinical contract research (CRO), which derives maximum revenue and Biotech Segment. It derives maximum revenue from Pre-clinical contract research (CRO) segment. Geographically, the company operates in Europe, North America and Other regions.
73GF Score

Get the complete analysis for CHIX:GUBRAC

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr354.50
Price
kr3,128.12
GF Value